This meta-analysis has not demonstrated any prognostic value for phosphorylation of FADD in ser-194, contrary to other types of cancers, such as lung cancer and lymphomas, in which FADD phosphorylated in ser-194 is associated with a worse tumour prognosis [11,12]. This evidence concerns the gene FADD and lymphoma.